NLC Health Investors DST
Legal trust name NLC Health Investors DST
DST interests are illiquid private securities. You may lose some or all of your investment. Distributions, tax treatment, and exit timing are not guaranteed. Review the current Private Placement Memorandum before investing.
NLC Health Investors DST is a Delaware statutory trust sponsored by Net Lease Capital Advisors, offering beneficial interests to outside investors. Issuer filings list Net Lease Capital executives Douglas F. Blough and Bruce S. MacDonald in Nashua, New Hampshire, as related persons. The program's initial Form D, filed October 1, 2025, reported a total offering of about $145.5 million, a $150,000 minimum-investment field, and an intended duration exceeding one year. An amended notice dated March 6, 2026, reported roughly $145.2 million sold against that same offering amount.
Min $150k; $145.24M sold of $145.48M, only $237k remaining (Form D/A 3/6/26); first sale 10/15/25; 506(b), no public property data
Based on issuer-filed Form D notices through Mar 6, 2026. Amounts are self-reported, may lag current subscriptions, and do not confirm availability. A Form D filing does not mean the SEC approved, endorsed, or verified the offering.
Form D is an issuer notice filing. A filing does not mean the SEC approved, endorsed, or verified the offering.
Offering profile
Offering identity
NLC Health Investors DST is organized as a Delaware statutory trust and offered as beneficial interests, with Net Lease Capital Advisors named as sponsor 12. The issuer's Form D lists two executive officers as related persons, Douglas F. Blough and Bruce S. MacDonald, both care of Net Lease Capital Advisors LLC at 10 Tara Boulevard, Suite 501, Nashua, New Hampshire 2.
Issuer-filed offering figures
The initial Form D, filed October 1, 2025, reported a total offering amount of $145,476,941 with no amount sold as of that date and no date of first sale yet, and stated the issuer intended the offering to last more than one year; the filing recorded a $150,000 minimum-investment field for outside investors 2. An amended notice (D/A) dated March 6, 2026 reported $145,239,705 sold against the same $145,476,941 offering amount 3.
In the news
Frequently asked questions
Is NLC Health Investors DST currently active?
NLC Health Investors DST is classified by Top1031 as active. “Active” reflects the latest public record and does not confirm that interests remain available.
Where does Top1031 get the data for NLC Health Investors DST?
Top1031 tracks this offering from SEC Form D filings and cited sponsor disclosures. Filing data may lag current subscriptions and does not mean the SEC approved or verified the offering.
